Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
ImmuCell is a $65mm market cap animal health company whose core franchise is the First Defense line of products, which protect newborn calves against scours, a leading cause of death for young calves. Until the past...
— Tom Wetherald and Eddie Reilly
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on ImmuCell Corporation
ImmuCell Corporation ($ICCC) is an animal health company focused on developing and commercializing preventative biological products, led by its flagship First Defense franchise that treats calf scours (severe neonatal diarrhea in dairy and beef calves). The manager's bullish...
ImmuCell Corporation ($ICCC) is an animal health company focused on preventing scours in newborn dairy and beef cattle through its flagship First Defense product line. The manager holds...
More institutional theses from Minot Light Capital Partners
Suja Life produces and markets organic, cold-pressed juices and functional wellness shots under the Suja and Vive brands. The manager maintains...
Alliance Laundry provides commercial and industrial laundry equipment, machinery, and servicing solutions. The manager holds...
Mobia Medical is an emerging commercial-stage medical technology company that develops the Vivistim system, a vagus nerve stimulation device designed to restore upper extremity motor function in ischemic stroke survivors. Minot Light is...